Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
Status:
Unknown status
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this migraine prevention study is to evaluate the efficacy and safety of
AST-726 in moderate to severe migraine patients at one of two doses compared to placebo and
compared to a baseline period as measured by a reduction in the number of migraine days.